<DOC>
	<DOCNO>NCT01116180</DOCNO>
	<brief_summary>Hypothesis : Treating patient type 1 diabetes certain antihypertensive drug preserve cerebral function hypoglycaemia . Background : Studies find certain genetic variation leave subject type 1 diabetes prone hypoglycaemia . It think decline cognition hypoglycaemia leave risk severe hypoglycaemia . The idea tha suppress genetic phenotype well know antihypertensive drug improvement cognition occur remove patient tendency severe hypoglycaemia . Methods : The investigator want explore whether cerebral function improve hypoglycaemia subject type 1 diabetes mention genetic variation treat antihypertensive drug Candesartan .</brief_summary>
	<brief_title>Cognitive Function Electrocardiogram ( ECG ) During Hypoglycemia Blockade Renin-angiotensin System</brief_title>
	<detailed_description>We include 25 type 1 diabetic patient outpatient clinic . They already genotyped another trial . Each patient go two cycle hyperinsulinemic glucose clamp induce hypoglycemia . The study double blind , randomise placebocontrolled patient receive Candesartan placebo different cycle . In cycle patient receive either Candesartan placebo 7 day . After 8 day patient undergo hypoglycaemic clamp primary secondary endpoint measure . In hyperinsulinemic hypoglycaemic clamp patient undergo adjustment period towards euglycaemia . A period approximately 1 hour euglycemia , hour hypoglycemia period recovery towards euglycemia . In glycemic state primary secondary outcome measure .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<criteria>Type 1 diabetes Danish spoken write RAS activity score &gt; 7 diabetes duration &gt; 5 year pregnant safe anticonception Signed informed consent . Treatment ACE blocker An ARB og renin blocker Treatment antihypertensive drug Severe diabetic late complication Renal impairment Pregnancy breastfeed Previous reaction study medication Heart insufficiency ( NYHA 34 ) \ Known ischaemic heart disease Epilepsy Alcohol drug abuse Suspicion noncompliance , Plasma potassium &lt; 3.5 mmol/l &gt; 5.0 mmol/l .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Hypoglycaemia</keyword>
	<keyword>genetic susceptibility</keyword>
	<keyword>Renin angiotensin system activity</keyword>
</DOC>